Study: Long-term blood pressure variability and visual field progression in glaucoma

News
Article

A retrospective cohort study was designed to provide further information on the association between BP parameters and VF progression over time.

Female patient getting blood pressure taken in doctor's office Image credit: AdobeStock/bnenin

Image credit: AdobeStock/bnenin

A newly published study1 reported that higher mean blood pressure (BP) levels and higher standard deviation (SD) of BP are associated with faster progression of visual field (VF) defects in patients with glaucoma.

Vincent Q. Pham, BS, and colleagues from the Viterbi Family Department of Ophthalmology, Hamilton Glaucoma Center, Shiley Eye Institute, University of California, San Diego, La Jolla, CA, reported their results in JAMA Ophthalmology.

They pointed out that the association between blood pressure (BP) and glaucoma progression has been studied previously.2,3 Impaired autoregulation of the vasculature, especially in the optic nerve head, was proposed as a key risk factor for glaucomatous progression.4 However, it remains uncertain whether these vascular changes are a cause or a consequence of glaucoma, they commented.

Blood pressure study and findings

This was a retrospective cohort study designed to provide further information on the association between BP parameters and VF progression over time. The study included patients with suspected or confirmed glaucoma who had been part of the Diagnostic Innovations in Glaucoma Study and the African Descent and Glaucoma Evaluation Study. BP and VF testing was performed from November 2000 to December 2022.

The main outcome measures were the mean and SD values of the systolic and diastolic arterial pressures, which were incorporated into multivariable mixed-effect models to look at association between BP parameters and mean intraocular pressure (IOP) with rates of VF mean deviation loss. The BP parameters, including the mean arterial pressure (MAP), systolic arterial pressure (SAP), and diastolic arterial pressure (DAP) were analyzed, according to the authors, in 3 separate models each incorporating their mean values and SDs. Two-way interaction terms and 3-way interaction terms for each combination of the mean BP, SD of the BP, and the mean IOP were included in the multivariable analysis.

The cohort included 1,674 eyes of 985 patients (mean age, 61.2 years).

The investigators reported that the mean change in the VF mean deviation was −0.13 (95% confidence interval [CI], −0.16 to −0.10) decibels (dB) annually over a mean follow-up of 8.0 years.

The interaction terms of higher mean BP and higher SD of the BP were associated with faster annual mean deviation changes for the MAP (0.02; 95% CI, 0.01-0.04 dB annually per 1-mm Hg higher; P = 0.001) and DAP (0.02; 95% CI, 0.01-0.03 dB annually per 1-mm Hg higher; P < 0.001). The interaction term of the higher SD of the BP and higher mean IOP was associated with faster annual mean deviation changes for the MAP (0.01; 95% CI, 0.00-0.02 μm per 1-mm Hg higher; P = 0.003) and DAP (0.01; 95% CI, 0.00-0.01 μm per 1-mm Hg higher; P = 0.001).

The authors concluded, “In this cohort study, the higher mean BP and higher SD of blood pressure were associated with faster VF progression. These findings suggest that long-term variability of the BP may be a modifier of the association between the IOP and VF progression in glaucoma.”

References:
  1. Pham VQ, Nishida T, Moghimi S, et al.Long-term blood pressure variability and visual field progression in glaucoma. JAMA Ophthalmol. Published online November 14, 2024. doi:10.1001/jamaophthalmol.2024.4868
  2. Mohammadzadeh V, Su E, Mohammadi M, et al. Association of blood pressure with rates of macular ganglion cell complex thinning in patients with glaucoma. JAMA Ophthalmol. 2023;141:251-257. doi:10.1001/jamaophthalmol.2022.6092
  3. Jammal AA, Berchuck SI, Mariottoni EB, et al. Blood pressure and glaucomatous progression in a large clinical population. Ophthalmology. 2022;129:161-170. doi:10.1016/j.ophtha.2021.08.021
  4. Leung DYL, Tham CC. Normal-tension glaucoma: current concepts and approaches-A review. Clin Exp Ophthalmol. 2022;50:247-259. doi:10.1111/ceo.14043
Recent Videos
Eye care practitioners reported moderate to high satisfaction with lifitegrast's ability to improve signs of dry eye, according to Melissa Barnett, OD, FAAO, FSLS.
Neda Gioia, OD, CNS, FOWNS, details the positive feedback gained so far from other optometrists that have been prescribing the NutriTears supplement to their dry eye patients.
Damaris Raymondi, OD, FAAO, highlighted the importance of building patient-doctor trust to learn about these practices, which can include non-traditional treatments like chamomile or manuka honey eye drops.
Noreen Shaikh, OD, Magdalena Stec, OD, FAAO, and Brenda Bohnsack, MD, PhD, emphasize that collaboration and communication are key to proper diagnosis and treatment.
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
A. Paul Chous, MA, OD, FAAO, details a presentation on this year's updates on diabetes given at this year's Academy meeting
© 2024 MJH Life Sciences

All rights reserved.